The meeting is scheduled for July 28-31 in Boston. A fully virtual option will still be available to anyone interested. The meeting is scheduled for July 28-31 in Boston. A fully virtual option will still be available to anyone interested. | |
|
The new meta-analysis, published in JACC: Cardiovascular Imaging, included data from 22 different studies. The new meta-analysis, published in JACC: Cardiovascular Imaging, included data from 22 different studies. | |
|
The issues between these two systems appears to go back several years. The issues between these two systems appears to go back several years. | |
|
Exploring data from nearly 6,000 STEMI patients, the study's authors aimed to learn more about the impact of immediate vs. delayed PCI. Exploring data from nearly 6,000 STEMI patients, the study's authors aimed to learn more about the impact of immediate vs. delayed PCI. | |
|
After one year, the stroke rate for LAAO patients was just 1.53%. After one year, the stroke rate for LAAO patients was just 1.53%. | |
|
|
The two-year rates of all-cause mortality or disabling stroke were 4.3% for TAVR patients and 6.3% for SAVR patients. The two-year rates of all-cause mortality or disabling stroke were 4.3% for TAVR patients and 6.3% for SAVR patients. | |
|
Researchers evaluated data from 25 different randomized clinical trials, sharing their findings virtually at EuroPCR 2021. Researchers evaluated data from 25 different randomized clinical trials, sharing their findings virtually at EuroPCR 2021. | |
|
Patients given the SGLT2 inhibitor did experience improved outcomes, the researchers noted, but none of the differences were statistically significant. Patients given the SGLT2 inhibitor did experience improved outcomes, the researchers noted, but none of the differences were statistically significant. | |
|
|
A federal judge ruled patients lacked legal standing to sue, saying the potentially stolen information didn't rise to the level of "certainly impending injury." A federal judge ruled patients lacked legal standing to sue, saying the potentially stolen information didn't rise to the level of "certainly impending injury." | |
|
AI company Exscientia has received a vote of confidence approaching $1.2 billion in value from Bristol-Myers Squibb. AI company Exscientia has received a vote of confidence approaching $1.2 billion in value from Bristol-Myers Squibb. | |
|